ArticleTherapeutic advances in gastroenterology2023

Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients.

Camilla de Almeida Martins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.